Editas Medicine

BiotechnologySeries BCambridge, USeditasmedicine.com

Latest round

Series B

Last raised

Aug 2015

Total raised

$141M

Investors

16

About Editas Medicine

Editas Medicine, Inc.Founded in 2013 and headquartered in Cambridge, US, Editas Medicine specializes in genomic medicine and gene editing.4 mn.Editas Medicine is dedicated to developing genomic medicines utilizing CRISPR gene editing technology. Their primary focus is on experimental therapies for severe genetic diseases, targeting conditions like sickle cell disease and beta thalassemia.34 mn.4 mn, to support the development of new genomic therapies targeting serious genetic diseases. The company aims to expand its market reach specifically into regions with high unmet medical needs, including additional markets in Europe and Asia by 2025. This strategic growth will focus on advancing their product pipeline towards clinical trials and eventual market introduction.

Who invested in Editas Medicine

16 investors across 2 rounds

See all investors in Editas Medicine

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 4, 2015

    Amount

    $120M

    Investors

    Locked

  2. Series A

    Nov 20, 2013

    Amount

    $21M

    Investors

    Locked

Questions about Editas Medicine

Who invested in Editas Medicine?

Editas Medicine has 16 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Editas Medicine raised?

Editas Medicine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Editas Medicine last raise money?

Editas Medicine's most recent round on record is a Series B, in Aug 2015.

What does Editas Medicine do?

Editas Medicine is a biotechnology company.

Where is Editas Medicine headquartered?

Editas Medicine is headquartered in Cambridge, US.

Which VCs invest in companies like Editas Medicine?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Editas Medicine's stage. Their profiles are linked below.

Raising like Editas Medicine? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.